Search research articles
Contact Us
Filters
Showing results (1-10 of 134) with videos related to
Page
of 14
Sort By:
DNA Repair
|
October 4, 2011
DNA repair inhibitors: where do we go from here?
Mark R Kelley
Anticancer Research
|
August 28, 2004
Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone
Meihua Luo, Mark R Kelley
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
DNA repair proteins as molecular targets for cancer therapeutics
Mark R Kelley, Melissa L Fishel
Neural Regeneration Research
|
March 3, 2017
Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage
Mark R Kelley, Jill C Fehrenbacher
Molecular Aspects of Medicine
|
June 15, 2007
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
Melissa L Fishel, Mark R Kelley
Journal of Cellular Signaling
|
December 5, 2024
Combating PDAC Drug Resistance: The Role of Ref-1 Inhibitors in Accelerating Progress in Pancreatic Cancer Research
Eyram K Kpenu, Mark R Kelley
Molecular Cancer Therapeutics
|
June 24, 2004
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
Dong Wang, Meihua Luo, Mark R Kelley
Molecular Cancer Therapeutics
|
August 10, 2004
Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells
Mikael Rinne, David Caldwell, Mark R Kelley
DNA Repair
|
January 22, 2005
The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress
Michael R Vasko, Chunlu Guo, Mark R Kelley
Antioxidants & Redox Signaling
|
August 22, 2008
Going ape as an approach to cancer therapeutics
Aditi Bapat, Melissa L Fishel, Mark R Kelley
Page
of 14
Search research articles
Search
Showing results (1-10 of 134) with videos related to
Sort By:
Page
of 14
DNA Repair
|
October 4, 2011
DNA repair inhibitors: where do we go from here?
Mark R Kelley
Anticancer Research
|
August 28, 2004
Inhibition of the human apurinic/apyrimidinic endonuclease (APE1) repair activity and sensitization of breast cancer cells to DNA alkylating agents with lucanthone
Meihua Luo, Mark R Kelley
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
DNA repair proteins as molecular targets for cancer therapeutics
Mark R Kelley, Melissa L Fishel
Neural Regeneration Research
|
March 3, 2017
Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage
Mark R Kelley, Jill C Fehrenbacher
Molecular Aspects of Medicine
|
June 15, 2007
The DNA base excision repair protein Ape1/Ref-1 as a therapeutic and chemopreventive target
Melissa L Fishel, Mark R Kelley
Journal of Cellular Signaling
|
December 5, 2024
Combating PDAC Drug Resistance: The Role of Ref-1 Inhibitors in Accelerating Progress in Pancreatic Cancer Research
Eyram K Kpenu, Mark R Kelley
Molecular Cancer Therapeutics
|
June 24, 2004
Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition
Dong Wang, Meihua Luo, Mark R Kelley
Molecular Cancer Therapeutics
|
August 10, 2004
Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells
Mikael Rinne, David Caldwell, Mark R Kelley
DNA Repair
|
January 22, 2005
The multifunctional DNA repair/redox enzyme Ape1/Ref-1 promotes survival of neurons after oxidative stress
Michael R Vasko, Chunlu Guo, Mark R Kelley
Antioxidants & Redox Signaling
|
August 22, 2008
Going ape as an approach to cancer therapeutics
Aditi Bapat, Melissa L Fishel, Mark R Kelley
Page
of 14